Appointment as Liquidator

Valeant Pharmaceuticals Australasia Pty Ltd

ACN: 001083352

ABN: 64001083352

Published: 5/8/2019
Notice is given that at a general meeting of the members of the Company held on 05 August 2019, it was resolved that the Company be wound up and that Michael Billingsley be appointed liquidator(s).

Eclipse Tower, Level 19, 60 Station Street, Parramatta 2150

EclipseTowerLevel1960StationStreet null 2150
E-mail: amatti@deloitte.com.au